glp 1 for alcohol use disorder GLP-1s Hold Promise as Treatment GLP-1 medications: The next big

Clinical research involving approximately 900 participants across six human trials has validated AOD-9604 s selective fat-targeting effects

In the first subgroup (ALC vs placebo), three studies 15,21,23 reported no AEs in either arm, and one 16 found no between-group difference

Additionally, they inhibit the secretion of glucagon, a hormone that raises blood sugar levels, and slow gastric emptying, leading to a prolonged feeling of fullness and reduced appetite

Well dive deep into their benefits, absorption rate, purity, efficacy, and possible side effects to help you make an informed decision on which one to choose